Policymakers need to make sense of the data so as to predict and manage what’s happening. To address this need, we developed a visualisation tool to track and predict country-level COVID-19 cases.
It’s still reasonably easy to catch a cold even during lockdown.
BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.
The microbiologist who directs the National Emerging Infectious Diseases Laboratories at Boston University explains all the biosafety precautions in place that help him feel safer in the lab than out.
Scientists get up close and personal with deadly pathogens to give doctors the tools they need to treat people sickened by germs. The key is keeping the researchers – and everyone around them – safe.
The Gambia’s success in eliminating trachoma means that resources previously allocated to combating the disease can now be reallocated to other public health conditions
By merging genomics with classical epidemiology, researchers are able to predict new disease outbreaks based on which viral variants are on the rise.
Direct-acting antivirals have mostly been used in countries with high incomes. These drugs would be effective against most hepatitis C strains. which are primarily low-income countries.
The US lags in testing coronavirus samples from COVID-19 patients, which can help track the spread of the virus and the emergence of new variants. But labs are ramping up this crucial surveillance.
Ebola seems to be able to lay dormant in people for many years before causing disease again.
Cuba’s access to internationally produced vaccines was nearly impossible due to the U.S. blockade. Its decision to make its own vaccines stands to pay off handsomely.
Infectious dysentery, usually found in developing countries with poor living conditions, is turning up in Vancouver’s most marginalized neighbourhood.
South Africa’s long-awaited TB prevalence survey results were recently released. They reveal that the country has a much higher burden of TB than previously thought.
Shoring up surveillance and response systems and learning lessons from how the COVID-19 pandemic unfolded will help the world be ready the next time around.
You need a new shot every year because current flu vaccines provide limited and temporary protection. But researchers’ new strategy could mean a one-and-done influenza vaccine is on the way.
Vaccine hesitancy has resulted in multiple vaccine-preventable disease outbreaks. Research on vaccine hesitancy in South Africa is limited. But growing evidence suggests that it’s becoming a problem.
Scientists are experimenting with using dogs to sniff out people infected with COVID-19. But dogs aren’t the only animals with a nose for disease.
Fauci turns 80 this Dec. 24 – and he’s been on the national stage for decades. Here’s more about his work before COVID-19 and why he was perfectly poised to help the US respond to the pandemic.
A fast-moving equine flu cratered the US economy in the fall of 1872, showing all too clearly that horses were essential and deserved better treatment.
Combating social media disinformation regarding vaccines is critical to reversing the growth in vaccine hesitancy around the world.